• Je něco špatně v tomto záznamu ?

Pitfalls of pancreatobiliary endoscopy after Billroth II gastrectomy

B. Kianicka, P. Dite, P. Piskac,

. 2012 ; 59 (113) : 17-21.

Jazyk angličtina Země Řecko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc12024114

BACKGROUND/AIMS: The aim of this retrospective study is the analysis of the success rate of diagnostic and therapeutic endoscopic retrograde cholangiopancreatography (ERCP) in our group of patients with Billroth II gastrectomy. METHODOLOGY: The study of the group was carried out during 14 years, i.e. from November 1994 to December 2008. It retrospectively evaluates 120 patients with Billroth II gastrectomy. RESULTS: A cannulation success rate of 90.8% (109 of 120 patients) was reached in performing ERCP in 120 patients with Billroth II gastrectomy. There were normal ERCP results in 4 patients. ERCP results in the remaining 105 patients were pathological. Endoscopic treatment was started in all of these 105 patients immediately after diagnostic ERCP. Overall, therapeutic ERCP was completely successful in 91 of 105 patients (86.66%) who were originally treated with endoscopy. CONCLUSIONS: ERCP in patients with Billroth II gastrectomy is much more demanding in contrast with standard procedure due to different postoperative anatomy. ERCP success is determined mainly by great personal experience and skillfulness of the endoscopist. ERCP performed lege artis in patients with Billroth II gastrectomy is a highly effective and safe method where the success rate reached can be almost the same as in a normal anatomical situation.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12024114
003      
CZ-PrNML
005      
20121207104408.0
007      
ta
008      
120815s2012 gr f 000 0#eng||
009      
AR
024    7_
$a 10.5754/hge10186 $2 doi
035    __
$a (PubMed)22251517
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gr
100    1_
$a Kianicka, Bohuslav $u Department of Gastroenterology, St. Anne's University Hospital, Brno, Czech Republic. bohusalav.kianicka@fnusa.cz
245    10
$a Pitfalls of pancreatobiliary endoscopy after Billroth II gastrectomy / $c B. Kianicka, P. Dite, P. Piskac,
520    9_
$a BACKGROUND/AIMS: The aim of this retrospective study is the analysis of the success rate of diagnostic and therapeutic endoscopic retrograde cholangiopancreatography (ERCP) in our group of patients with Billroth II gastrectomy. METHODOLOGY: The study of the group was carried out during 14 years, i.e. from November 1994 to December 2008. It retrospectively evaluates 120 patients with Billroth II gastrectomy. RESULTS: A cannulation success rate of 90.8% (109 of 120 patients) was reached in performing ERCP in 120 patients with Billroth II gastrectomy. There were normal ERCP results in 4 patients. ERCP results in the remaining 105 patients were pathological. Endoscopic treatment was started in all of these 105 patients immediately after diagnostic ERCP. Overall, therapeutic ERCP was completely successful in 91 of 105 patients (86.66%) who were originally treated with endoscopy. CONCLUSIONS: ERCP in patients with Billroth II gastrectomy is much more demanding in contrast with standard procedure due to different postoperative anatomy. ERCP success is determined mainly by great personal experience and skillfulness of the endoscopist. ERCP performed lege artis in patients with Billroth II gastrectomy is a highly effective and safe method where the success rate reached can be almost the same as in a normal anatomical situation.
650    _2
$a cholangiopankreatografie endoskopická retrográdní $x škodlivé účinky $7 D002760
650    _2
$a klinické kompetence $7 D002983
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a gastrektomie $x škodlivé účinky $x metody $7 D005743
650    _2
$a gastroenterostomie $x škodlivé účinky $7 D005763
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a pooperační komplikace $x diagnóza $x etiologie $x chirurgie $7 D011183
650    _2
$a prediktivní hodnota testů $7 D011237
650    _2
$a reoperace $7 D012086
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a hodnocení rizik $7 D018570
650    _2
$a rizikové faktory $7 D012307
650    _2
$a časové faktory $7 D013997
650    _2
$a výsledek terapie $7 D016896
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
700    1_
$a Dite, Petr
700    1_
$a Piskac, Petr
773    0_
$w MED00002025 $t Hepato-gastroenterology $x 0172-6390 $g Roč. 59, č. 113 (2012), s. 17-21
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22251517 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120815 $b ABA008
991    __
$a 20121207104442 $b ABA008
999    __
$a ok $b bmc $g 946262 $s 781442
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 59 $c 113 $d 17-21 $i 0172-6390 $m Hepato-gastroenterology $n Hepatogastroenterology $x MED00002025
LZP    __
$a Pubmed-20120815/12/02
Zpět

Najít záznam

Citační ukazatele

    Možnosti archivace